Ryuichi Hasegawa

[Progress on OECD chemicals programme (7)--SIAM 15 in Boston, 2002].

Mariko Matsumoto, Akihiko Hirose, Mika Takahashi, 2005, Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences.

UGT1A1 Haplotypes Associated with Reduced Glucuronidation and Increased Serum Bilirubin in Irinotecan‐administered Japanese Patients with Cancer

Kazuo Komamura, Naoyuki Kamatani, Noriko Katori, 2004, Clinical pharmacology and therapeutics.

Proposal of new uncertainty factor application to derive tolerable daily intake.

Michael L Dourson, Akihiko Hirose, Atsushi Ono, 2010, Regulatory toxicology and pharmacology : RTP.

A category approach to predicting the repeated-dose hepatotoxicity of allyl esters.

Yuki Sakuratani, Ovanes Mekenyan, Akihiko Hirose, 2013, Regulatory toxicology and pharmacology : RTP.

Safety assessment of boron by application of new uncertainty factors and their subdivision.

Michael L Dourson, Akihiko Hirose, Atsushi Ono, 2013, Regulatory toxicology and pharmacology : RTP.

Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetes.

Tatsuo Yanagawa, Toshiaki Shibasaki, Ryuichi Hasegawa, 2006, Diabetes research and clinical practice.

[Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].

Mitsuo Saito, Mutsuko Hirata-Koizumi, Ryuichi Hasegawa, 2005, Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences.

A category approach to predicting the hemolytic effects of ethylene glycol alkyl ethers in repeated-dose toxicity.

Yuki Sakuratani, Ovanes Mekenyan, Ryuichi Hasegawa, 2012, The Journal of toxicological sciences.

Unexpected nephrotoxicity induced by tetrabromobisphenol A in newborn rats.

Eiichi Kamata, Ryuichi Hasegawa, Makoto Ema, 2004, Toxicology letters.